This course covers the research on psychedelics for treating mental health disorders and the clinical issues involved in providing competent, safe, trauma-informed psychedelic-assisted psychotherapy (PAP). It is designed for healthcare professionals seeking an overview of this emerging field.
Harvard University
English
10 weeks
Psychedelic-Assisted Psychotherapy: The Next Frontier, offers healthcare professionals a comprehensive overview of the emerging field of PAP. Attendees will gain knowledge of classical and novel psychedelic agents, as well as an understanding of what PAP entails. They will also learn about various models of psychotherapy that may support PAP and the principles of harm reduction, and a trauma-informed approach.
Delivered by Cambridge Health Alliance, this course is specifically designed for Primary Care Physicians, Specialty Physicians, Psychologists, Social Workers, and Counsellors. However, it may also interest those practicing in related fields such as Family Medicine, Internal Medicine, Lifestyle and Mind-Body Medicine, Psychiatry and Neurology, and Psychology and Mental Health.
The course starts at $175 and qualifies for CE and CME credits. Currently, the course is not being offered.
Primary care physicians, specialty physicians, psychologists, social workers, and counselors; may also interest clinicians in family medicine, internal medicine, lifestyle and mind-body medicine, psychiatry and neurology, and psychology and mental health.
Harvard University hosts multiple psychedelic research initiatives including the Study of Psychedelics in Society and Culture (a $16M program), the MGH Center for the Neuroscience of Psychedelics, and the Harvard Law School POPLAR project addressing psychedelic policy reform. These programs span neuroscience, cultural studies, and legal advocacy to advance scientific and societal understanding of psychedelics.
Primary care physicians, specialty physicians, psychologists, social workers, and counselors; may also interest clinicians in family medicine, internal medicine, lifestyle and mind-body medicine, psychiatry and neurology, and psychology and mental health.
Format: Hybrid. Time commitment: 10 weeks.
The listed price is $175. Confirm the latest tuition, fees, and payment options with [object Object].
Accreditation note: Accredited course offered by Cambridge Health Alliance.. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By Clerkenwell Health
Shares course skills and categories
Psilocybin therapy courses covering clinical and educational material on psilocybin-assisted psychotherapy, preparation, dosing, and integration. Listings on the page vary by provider and format.
Next cohort: May 20, 2026
By Fluence
Shares course skills and categories
Psychedelic Therapist Training covers the use of psychedelic substances in therapy, with topics including history, current research, safety, harm reduction, ethics, and session facilitation. It is presented as training for mental health and medical professionals, as well as others interested in psychedelic therapy.
Next cohort: Sep 1, 2026
By Alma Institute
Shares course skills and categories
Ketamine-assisted therapy courses focused on clinical and practice-related skills for working with ketamine therapy. The page groups courses and related training topics connected to ketamine-assisted care.
Next cohort: Jul 13, 2026